FUNDAMENTAL ANALYSIS
RMD
ResMed|
FUNDAMENTAL RATING
FUNDAMENTAL SCORE
77 / 100
Summary
ResMed| has grown revenue and net income across its recent annual filings, with both series moving up together. Revenue compounded at 10.21% a year (CAGR, or compound annual growth rate); net income compounded at 19.28% a year. Latest annual revenue rose 9.9% (YoY, or year-over-year) and latest annual net income rose 8.8%, and the most recent reported quarter posted $418.41M in net income. Assets cover liabilities 3.77 times, a comfortable cushion. The Altman Z-score of 11.0 sits in the safe zone, which begins at 2.99. The Piotroski F-Score of 6 on a 0 to 9 quality scale is a mixed earnings-quality reading. The P/E (TTM) of 20.94 and EPS (TTM, Diluted) of $10.98 roughly align with the S&P 500 average; the next report must show whether net income growth reaccelerates from the current annual pace.
Revenue — Annual Comparison
Net Income — Annual Comparison
Quarterly Detail Charts
Quarterly Revenue
Quarterly Net Income
Piotroski F-Score Breakdown
6/9 · Neutral
Profitability — Net income positive this fiscal year
Pass
Return on Assets — Return on Assets improved year-over-year
Fail
Cash flow positive — Cash from operations positive this fiscal year
Pass
Earnings quality — Cash from operations exceeds net income
Fail
Leverage down — Long-term debt / total assets improved
Pass
Liquidity up — Current ratio improved year-over-year
Fail
No share dilution — Share count did not increase year-over-year
Pass
Margin up — Gross margin expanded year-over-year
Pass
Asset efficiency — Asset turnover improved year-over-year
Pass
Data Source
This dashboard applies a modified 9-signal Piotroski F-Score (Piotroski, 2000) and Altman Z-Score models. Fundamental filing data is sourced from the SEC's EDGAR XBRL database (primary), with API Ninjas as backup for freshly-filed 10-Ks not yet in SEC. Live price, market cap, and EPS display use Tiingo end-of-day data. This page is informational analysis, not investment advice. See Financial Disclaimer.
Recent Filings
Formula & Methodology
Trend inputAnnual revenue and net income year-over-year direction contributes 20% of the score.
Piotroski inputModified 9-test Piotroski F-Score (Quality) contributes 40% of the score.
Altman inputAltman Z-Score (Distress) contributes 40% of the score.
Rating ruleFormula: Trend (20%) + Piotroski F-Score (40%) + Altman Z-Score (40%). Trend blends annual revenue and net income year-over-year direction. Piotroski is the modified 9-test variant (7 classic + 2 cash-flow tests). Altman uses the 1968 Z-Score with Safe/Grey/Distress zones. Combined blend uses ±0.45 thresholds: Bullish at +0.45 or higher, Bearish at -0.45 or lower, Neutral in between. Missing sub-signals count as Neutral (0) and weights are not re-normalized — a company with fewer available signals must earn its rating from stronger reads on the remaining pillars.